97 related articles for article (PubMed ID: 23245212)
41. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
42. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
43. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
Deane M; Norton JD
Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
[TBL] [Abstract][Full Text] [Related]
44. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
45. Immunoglobulin light chain gene rearrangements display hierarchy in absence of selection for functionality in precursor-B-ALL.
van der Burg M; Barendregt BH; Szczepañski T; van Wering ER; Langerak AW; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1448-53. PubMed ID: 12145684
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
[TBL] [Abstract][Full Text] [Related]
47. Clinical relevance of immunoglobulin mutation analysis.
Hummel M; Stein H
Curr Opin Oncol; 2000 Sep; 12(5):395-402. PubMed ID: 10975545
[TBL] [Abstract][Full Text] [Related]
48. Blastic transformation of mantle cell lymphoma: genetic evidence for a clonal link between the two stages of the tumour.
László T; Matolcsy A
Histopathology; 1999 Oct; 35(4):355-9. PubMed ID: 10564390
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma.
Ek S; Ortega E; Borrebaeck CA
Leuk Res; 2005 Feb; 29(2):205-13. PubMed ID: 15607370
[TBL] [Abstract][Full Text] [Related]
50. Dual expression of surface immunoglobulin light chains is real: First reported case in mantle cell lymphoma.
Wang WJ; Gehris BT; Ahmed AA; Naik U; Chen L
Int J Lab Hematol; 2023 Jun; 45(3):e64-e67. PubMed ID: 36537151
[No Abstract] [Full Text] [Related]
51. Molecular genetic characterization reveals new subsets of mantle cell lymphoma.
Thelander EF; Rosenquist R
Leuk Lymphoma; 2008 Jun; 49(6):1042-9. PubMed ID: 18452063
[TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin chain loss in hybridoma lines.
Köhler G
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2197-9. PubMed ID: 6769123
[TBL] [Abstract][Full Text] [Related]
53. Cryptic insertions of the immunoglobulin light chain enhancer region near
Fuster C; Martín-Garcia D; Balagué O; Navarro A; Nadeu F; Costa D; Prieto M; Salaverria I; Espinet B; Rivas-Delgado A; Terol MJ; Giné E; Forcada P; Ashton-Key M; Puente XS; Swerdlow SH; Beà S; Campo E
Haematologica; 2020 Aug; 105(8):e408-e411. PubMed ID: 31753927
[No Abstract] [Full Text] [Related]
54. Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity.
Schraders M; Oeschger S; Kluin PM; Hebeda K; Schuuring E; Groenen PJ; Hansmann ML; van Krieken JH
Mod Pathol; 2009 Mar; 22(3):416-25. PubMed ID: 19136929
[TBL] [Abstract][Full Text] [Related]
55. Two cases of acquired immunodeficiency syndrome-related lymphoma with simultaneous clonal rearrangements of B-cell and T-cell genes.
Samoszuk M; Nguyen V
Blood; 1994 Mar; 83(5):1444-5. PubMed ID: 8118048
[No Abstract] [Full Text] [Related]
56. Lymphoma with multi-gene rearrangement on the level of immunoglobulin heavy chain, light chain, and T-cell receptor beta chain.
Szczepański T; Langerak AW; van Dongen JJ; van Krieken JH
Am J Hematol; 1998 Sep; 59(1):99-100. PubMed ID: 9723588
[No Abstract] [Full Text] [Related]
57. Rapid distinction of acute demyelinating disorders and central nervous system lymphoma by molecular analysis of cerebrospinal fluid cells.
Wildemann B; Jansen O; Haas J; Vogt-Schaden ME; Storch-Hagenlocher B
J Neurol; 2001 Feb; 248(2):127-30. PubMed ID: 11284130
[TBL] [Abstract][Full Text] [Related]
58. Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-association.
Sargunas PR; Spangler JB
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2208330119. PubMed ID: 35776537
[No Abstract] [Full Text] [Related]
59. Murine mantle cell lymphoma model cell line.
Smith MR; Joshi I; Pei J; Slifker M; Jin F; Testa JR; Al-Saleem T
Leukemia; 2013 Jul; 27(7):1592-4. PubMed ID: 23271511
[No Abstract] [Full Text] [Related]
60. D is for different-differences between H and L chain rearrangement.
Louzoun Y; Luning Prak E; Litwin S; Weigert M
Semin Immunol; 2002 Jun; 14(3):239-41. PubMed ID: 12160656
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
